FDA Panel to Review Abbott Laboratories’s Meridia on Sept. 15, 2010

Reuters -- Abbott Laboratories' (ABT.N) weight loss drug Meridia will be reviewed by an advisory panel to the U.S. Food and Drug Administration on September 15, the company said on Friday.